These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8858630

  • 1. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
    Threlkeld AB, Assalian AA, Allingham RR, Shields MB.
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC.
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS, Cheung P, Hui SP.
    Jpn J Ophthalmol; 2005 Sep; 49(2):89-92. PubMed ID: 15838723
    [Abstract] [Full Text] [Related]

  • 7. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
    Allf BE, Shields MB.
    Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
    [Abstract] [Full Text] [Related]

  • 8. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
    Sterk CC, Renzenbrink-Bubberman AC, van Best JA.
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
    Onal S, Gozum N, Gucukoglu A.
    Ophthalmic Surg Lasers Imaging; 2005 Jun; 36(6):457-62. PubMed ID: 16355950
    [Abstract] [Full Text] [Related]

  • 12. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R, Perkins TW, Gangnon R, Kaufman PL, Heatley GA.
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
    Cullom RD, Schwartz LW.
    Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty.
    Robin AL.
    Ophthalmic Surg; 1991 Jan; 22(1):31-7. PubMed ID: 2014108
    [Abstract] [Full Text] [Related]

  • 19. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL, Ritch R, Shin D, Smythe B, Mundorf T, Lehmann RP.
    Trans Am Ophthalmol Soc; 1995 Jan; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [Abstract] [Full Text] [Related]

  • 20. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP, Domack H, Schmidt V.
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.